Revenue
2018
2019
2020
2021
2022
2023
2024
2025
Sensus Healthcare, Inc. (SRTS)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $27.5M | $41.8M | $24.4M | $44.5M | $27.0M | $9.6M | $27.3M | $26.4M | $20.6M | $14.8M | $10.3M |
| Gross profit | $11.9M | $24.4M | $14.1M | $29.6M | $17.0M | $5.2M | $17.6M | $16.9M | $13.8M | $9.8M | $6.6M |
| Research & development | $7.8M | $4.2M | $3.7M | $3.5M | $3.4M | $4.2M | $6.4M | $6.3M | $5.5M | $1.8M | $1.5M |
| Operating expenses | $22.2M | $16.3M | $14.4M | $14.8M | $12.9M | $13.5M | $19.5M | $18.9M | $17.5M | $10.2M | $6.8M |
| Operating income | −$10.3M | $8.1M | −$382,000 | $14.8M | $4.1M | −$8.2M | −$2.0M | −$2.0M | −$3.7M | −$363,119 | −$221,257 |
| EBITDAderived | −$9.9M | $8.3M | −$107,000 | $15.1M | $4.7M | −$7.5M | −$1.4M | −$1.3M | −$3.3M | −$25,536 | $94,342 |
| Net income | −$7.7M | $6.6M | $485,000 | $24.2M | $4.1M | −$6.8M | −$1.7M | −$2.0M | −$3.7M | −$346,448 | −$237,267 |
| Basic EPSper diluted share | -$0.47 | $0.41 | $0.03 | $1.47 | $0.25 | -$0.42 | -$0.10 | -$0.14 | -$0.28 | -$0.03 | -$0.08 |
| Diluted EPSper diluted share | -$0.47 | $0.41 | $0.03 | $1.46 | $0.25 | -$0.42 | -$0.10 | -$0.14 | -$0.28 | -$0.03 | -$0.08 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 12, 2026Form 4 | Sachetta EricDirector | BuyCommon Stock | 1.5K | $3.34 | $5.0K | 143.6K |
| Feb 24, 2026Form 4 | Sachetta EricDirector | BuyCommon Stock | 2.0K | $3.81 | $7.6K | 142.1K |
| Nov 21, 2025Form 4 | Sachetta EricDirector | BuyCommon Stock | 7.0K | $3.93 | $27.5K | 140.1K |
| Nov 18, 2025Form 4 | Sardano MichaelPRESIDENT AND GENERAL COUNSEL | BuyCommon Stock | 1.0K | $3.80 | $3.8K | 118.8K |
| Nov 18, 2025Form 4 | Sardano Joseph CCHIEF EXECUTIVE OFFICER | BuyCommon Stock | 25.0K | $4.03 | $100.8K | 1.20M |